Pflug Koory’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.3K Hold
225
0.01% 256
2026
Q1
$34.4K Hold
225
0.02% 249
2025
Q4
$31K Sell
225
-300
-57% -$39.3K 0.01% 258
2025
Q3
$67.3K Hold
525
0.03% 212
2025
Q2
$63.5K Hold
525
0.03% 214
2025
Q1
$58.5K Hold
525
0.03% 212
2024
Q4
$51.1K Hold
525
0.03% 219
2024
Q3
$60.4K Buy
+525
New +$59.6K 0.03% 215
2024
Q1
$53.2K Hold
550
0.03% 219
2023
Q4
$55.5K Hold
550
0.03% 221
2023
Q3
$56K Hold
550
0.03% 214
2023
Q2
$55.5K Hold
550
0.03% 224
2023
Q1
$50.6K Hold
550
0.03% 231
2022
Q4
$50K Hold
550
0.03% 231
2022
Q3
$42K Hold
550
0.03% 245
2022
Q2
$46K Hold
550
0.03% 243
2022
Q1
$48K Sell
550
-75
-12% -$6.49K 0.02% 257
2021
Q4
$55K Hold
625
0.03% 254
2021
Q3
$51K Sell
625
-185
-23% -$16.6K 0.03% 248
2021
Q2
$74K Buy
810
+100
+14% +$8.9K 0.04% 223
2021
Q1
$61K Buy
710
+225
+46% +$20.2K 0.03% 226
2020
Q4
$46K Hold
485
0.03% 241
2020
Q3
$42K Buy
485
+65
+15% +$5.63K 0.03% 239
2020
Q2
$37K Hold
420
0.03% 240
2020
Q1
$35K Sell
420
-13
-3% -$1.16K 0.03% 230
2019
Q4
$41K Hold
433
0.03% 241
2019
Q3
$38K Hold
433
0.03% 241
2019
Q2
$40K Sell
433
-50
-10% -$4.23K 0.03% 232
2019
Q1
$42K Hold
483
0.03% 235
2018
Q4
$37K Hold
483
0.03% 229
2018
Q3
$37K Hold
483
0.03% 237
2018
Q2
$33K Hold
483
0.03% 243
2018
Q1
$35K Hold
483
0.03% 233
2017
Q4
$36K Hold
483
0.03% 232
2017
Q3
$37K Hold
483
0.03% 233
2017
Q2
$36K Hold
483
0.03% 239
2017
Q1
$32K Hold
483
0.03% 236
2016
Q4
$32 Buy
+483
New +$31.3K 0.03% 224

Other funds holding NVS

Pflug Koory's NVS Position: Q2 2026 in Review

Pflug Koory held its Novartis (NVS) position steady in Q2 2026 at 225 shares worth $35.3K. The position accounts for 0.01% of the portfolio, ranked #256.

Pflug Koory first reported a position in NVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $74K in Q2 2021. 366 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Pflug Koory held 225 shares of Novartis worth $35.3K as of Q2 2026.
  • Pflug Koory left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.01% of Pflug Koory's portfolio in Q2 2026, its #256 holding.
  • Pflug Koory first reported a position in Novartis in Q4 2016 and has held it in 38 quarters since.
  • Pflug Koory's Novartis position peaked at $74K in Q2 2021.
  • 366 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Pflug Koory's 13F filing for Q2 2026, filed 21 Jul 2026.